2seventy bio, Inc. (NASDAQ:TSVT) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the 2seventy bio Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
2Seventy Bio Inc. (TSVT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Beryl Capital Management David Alexander Witkin | 4,250,000 | $20,995,000 | 7.84% | |
| 2. | Newtyn Management Noah Levy And Eugene Dozortsev | 2,534,836 | $12,522,090 | 1.98% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,497,526 | $12,337,778 | 0.14% | |
| 4. | GLG Partners Noam Gottesman | 2,043,026 | $10,092,549 | 0.03% | |
| 5. | Casdin Capital Eli Casdin | 2,000,000 | $9,880,000 | 0.81% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 40,000 | Director | 2,000,000 | 2024-03-26 | Filing | |
| $5.07 | 330,000 | Director | 1,960,000 | 2024-03-25 | Filing | |
| $5.12 | 147,377 | Director | 1,630,000 | 2024-03-22 | Filing | |
| $4.90 | 300,000 | Director | 1,482,623 | 2024-03-21 | Filing | |
| $5.96 | 86,414 | Large Shareholder | 5,142,111 | 2023-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.95 | 2,298 | 254,193 | 2025-03-17 | Filing | ||
| $4.95 | 5,092 | 1,121,034 | 2025-03-17 | Filing | ||
| $4.95 | 2,592 | 444,387 | 2025-03-17 | Filing | ||
| $4.93 | 5,142,111 | Large Shareholder | 0 | 2025-03-11 | Filing | |
| $4.93 | 5,142,111 | Large Shareholder | 0 | 2025-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,681,675 | $23,127,474 | 0% | |
| 2. | 3,971,873 | $19,621,051 | 0% | |
| 3. | 2,967,078 | $14,657,367 | 0% | |
| 4. | 2,819,469 | $13,928,177 | 0% | |
| 5. | 2,516,505 | $12,431,535 | 0% |
News See All
2seventy bio, Inc. (NASDAQ:TSVT) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the 2Seventy Bio Second Quarter 2024 Earnings Conference Call.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript
2seventy bio, Inc. misses on earnings expectations. Reported EPS is $-0.81 EPS, expectations were $-0.72.
2seventy bio, Inc. (NASDAQ:TSVT) Q4 2023 Earnings Call Transcript
2seventy bio, Inc. beats earnings expectations. Reported EPS is $-1.11, expectations were $-1.22.
10 Stocks That Are About To Explode
The stock market has been quite tumultuous recently.
5 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the five oversold small cap stocks to buy.
Billionaire Hedge Funds
